Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnilever Regulatory News (ULVR)

Share Price Information for Unilever (ULVR)

Share Price is delayed by 15 minutes
Get Live Data
4,401.50    117.00 (2.73%)
Bid:
4,382.00
Ask:
4,383.50
Spread: 1.50 (0.034%)
Market Cap: £95.31b
ULVR Live PriceLast checked at - London Stock Exchange

Intraday Unilever Share Chart

Share Buy-Back Programme

30 Apr 2026 07:01

RNS Number : 5598C
Unilever PLC
30 April 2026
 

2026 Share Buyback

 

London, 30 April 2026. Unilever PLC ("Unilever") announces that it is today commencing a new share buyback of up to €1.5 billion (the "SBB"), as set out in its full year 2025 results on 12 February 2026 and reiterated in its first quarter trading statement released today.

The purpose of the SBB is to reduce the capital of Unilever and it will take place within the limitations of the authority granted to the Board of Unilever by its general meeting held on 30 April 2025 (as amended at the general meeting held on 21 October 2025 relating to the share consolidation of Unilever shares). Accordingly, the maximum number of shares to be bought back by Unilever is 223,263,040.

The SBB commences today, 30 April 2026, and will end on or before 6 July 2026.

Any repurchases of shares under the SBB are expected to be announced on a weekly basis and in any event will be announced no later than the end of the seventh trading day following the date of the repurchase.

Unilever has entered into non-discretionary instructions with Morgan Stanley & Co. International PLC to conduct the SBB on its behalf and to make trading decisions under the SBB independently of Unilever.

 

ENDS

 

Enquiries

Media:

Unilever Press Office

press-office.london@unilever.com

Investors:

Investor Relations Team investor.relations@unilever.com 

 

About Unilever

Unilever is a global consumer goods business comprised of four business groups: Beauty & Wellbeing, Personal Care, Home Care and Foods. Unilever's products are used by approximately 3.7 billion people every day, with sales in around 190 countries. We have around 96,000 employees and generated sales of €50.5 billion in 2025.

For more information about Unilever and our brands, please visit www.unilever.com.

 

Safe Harbour

This announcement may contain forward-looking statements, including 'forward-looking statements' within the meaning of the United States Private Securities Litigation Reform Act of 1995, including with relation to Unilever's share buyback, its purpose and timetable. All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. Words such as 'will', 'aim', 'expects', 'anticipates', 'intends', 'looks', 'believes', 'vision', 'ambition', 'target', 'goal', 'plan', 'potential', 'work towards', 'may', 'milestone', 'objectives', 'outlook', 'probably', 'project', 'risk', 'seek', 'continue', 'projected', 'estimate', 'achieve' or the negative of these terms and other similar expressions of future performance or results, and their negatives, are intended to identify such forward-looking statements. These forward-looking statements are based upon current expectations and assumptions regarding anticipated developments and other factors affecting the Unilever Group (the 'Group'). They are not historical facts, nor are they guarantees of future performance or outcomes. All forward-looking statements contained in this announcement are expressly qualified in their entirety by the cautionary statements contained or referred to in this announcement. Readers should not place undue reliance on forward-looking statements.

Because these forward-looking statements involve known and unknown risks and uncertainties, a number of which may be beyond the Group's control, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. The forward-looking statements are based on our beliefs, assumptions and expectations regarding anticipated developments and other factors affecting the Group, taking into account all information currently available to us. They are not historical facts, nor are they guarantees of future performance or outcomes. All forward-looking statements contained in this announcement are expressly qualified in their entirety by the cautionary statements contained or referred to in this announcement. Readers should not place undue reliance on forward-looking statements.

The forward-looking statements speak only as of the date of this announcement. Except as required by any applicable law or regulation, the Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Group's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. New risks and uncertainties arise over time, and it is not possible for us to predict those events or how they may affect us. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

Further details of potential risks and uncertainties affecting the Group are described in the Group's filings with the London Stock Exchange, Euronext Amsterdam and the US Securities and Exchange Commission, including in the Annual Report on Form 20-F 2025 and the Unilever Annual Report and Accounts 2025 available on our corporate website www.unilever.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSGSGDSBUXDGLG
Date   Source Headline
3rd Nov 202512:20 pmRNSTotal Voting Rights
30th Oct 20251:34 pmRNSPublication of Final Terms
30th Oct 202512:00 pmRNSStatement re AGM Vote
28th Oct 20254:00 pmRNSDirector/PDMR Shareholding
27th Oct 20255:16 pmRNSDirector/PDMR Shareholding
24th Oct 20254:19 pmRNSPublication Supplement
23rd Oct 20257:00 amRNSQ3 2025 Trading Statement
21st Oct 202510:20 amRNSResult of General Meeting
21st Oct 20257:00 amRNSStatement regarding Demerger & Share Consolidation
7th Oct 202510:42 amRNSAppointment of NED
2nd Oct 20257:00 amRNSShareholder Circular, Notice of General Meeting
1st Oct 20254:35 pmRNSTotal Voting Rights
22nd Sep 20257:00 amRNSDirector/PDMR Shareholding - Amendment
19th Sep 20251:18 pmRNSDirector/PDMR Shareholding
17th Sep 20253:41 pmRNSDirector/PDMR Shareholding
17th Sep 20259:40 amRNSDirector/PDMR Shareholding
16th Sep 20257:00 amRNSDirectorate Change
15th Sep 202511:57 amRNSBlock listing Interim Review
3rd Sep 20256:07 pmRNSPublication of Final Terms
1st Sep 20254:13 pmRNSTotal Voting Rights
1st Aug 20252:33 pmRNSTotal Voting Rights
31st Jul 20253:03 pmRNSPublication of Supplement
31st Jul 20257:00 amRNS2025 First Half Results
1st Jul 202512:55 pmRNSTotal Voting Rights
1st Jul 20259:35 amRNSDirector/PDMR Shareholding
20th Jun 20253:25 pmRNSDirector/PDMR Shareholding
18th Jun 20252:28 pmRNSDirector/PDMR Shareholding
17th Jun 20254:06 pmRNSDirector/PDMR Shareholding
2nd Jun 20252:18 pmRNSTotal Voting Rights
30th May 20256:29 pmRNSCompletion of Share Buyback
30th May 20256:28 pmRNSTransaction in Own Shares
30th May 20255:36 pmRNSPUBLICATION OF UFN FINANCIAL STATEMENTS
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:00 amRNSTransaction in Own Shares
28th May 20257:00 amRNSTransaction in Own Shares
27th May 20257:00 amRNSTransaction in Own Shares
23rd May 20257:00 amRNSTransaction in Own Shares
22nd May 20257:00 amRNSTransaction in Own Shares
21st May 20259:22 amRNSPublication of Final Terms: Unilever Bonds
21st May 20257:00 amRNSTransaction in Own Shares
20th May 20257:00 amRNSTransaction in Own Shares
19th May 20257:00 amRNSTransaction in Own Shares
16th May 20257:00 amRNSTransaction in Own Shares
15th May 20257:00 amRNSTransaction in Own Shares
14th May 20257:00 amRNSTransaction in Own Shares
13th May 20257:00 amRNSTransaction in Own Shares
12th May 20257:00 amRNSTransaction in Own Shares
9th May 20257:00 amRNSTransaction in Own Shares
8th May 20257:00 amRNSTransaction in Own Shares
7th May 20252:38 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.